Fairman Group »

AstraZeneca shares owned by Fairman Group

Quarter-by-quarter ownership of AstraZeneca shares owned by Fairman Group from 13F filings

Historical chart of Fairman Group investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Fairman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Fairman Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $11k 124 91.93
2025-09-30 $9.5k 124 76.72

More positions owned by Fairman Group

Ishares Tr Core S&p500 Etf (IVV)
Accenture Plc Ireland Shs Class A (ACN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Essent (ESNT)
Ea Series Trust Strive 500 Etf (STRV)
W.R. Berkley Corporation (WRB)
Veeva Sys Cl A Com (VEEV)
Vanguard Index Fds Total Stk Mkt (VTI)
Blackrock Etf Trust Ii Ishares High Yie (HIMU)
Litman Gregory Fds Tr Imgp Dbi Managed (DBMF)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Msci Eafe Etf (EFA)
Vanguard Index Fds Large Cap Etf (VV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Fairman Group

Top funds holding AstraZeneca

PRIMECAP Management Company
Wellington Management Company
FMR
Fisher Investments
Franklin Resources
Capital Research and Management Company - Division 3
Goldman Sachs Group
Sanders Capital
Atlantic Trust
Dimensional Fund Advisors
BlackRock
Ameriprise Financial
Arrowstreet Capital, Limited Partnership
Citadel Advisors
Neuberger Berman Group

View all funds holding AstraZeneca